138 related articles for article (PubMed ID: 16343100)
21. fT3:fT4 ratio in Graves' disease - correlation with TRAb level, goiter size and age of onset.
Minasyan M; Dulęba A; Smalarz A; Stręk M; Bryniarski P; Przybylik-Mazurek E; Hubalewska-Dydejczyk A
Folia Med Cracov; 2020 Sep; 60(2):15-27. PubMed ID: 33252592
[TBL] [Abstract][Full Text] [Related]
22. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
[TBL] [Abstract][Full Text] [Related]
23. [Role of flowmetric analysis and of color-Doppler ultrasonography with contrast media in the different phases and follow-up of Graves' disease].
Amodio F; Di Martino S; Esposito S; Iorio S; Hierholzer J; Rea G; Bizzarro A; Vallone G
Radiol Med; 2001 Oct; 102(4):233-7. PubMed ID: 11740450
[TBL] [Abstract][Full Text] [Related]
24. Characterization and clinical relevance of circulating CD4+CD28- T cells in Graves' disease.
Wang F; Chen L; Shen Q; Liu T; Jiang L; Gu X; Chen L; Sun J; Liu C
Immunol Lett; 2015 May; 165(1):47-51. PubMed ID: 25839128
[TBL] [Abstract][Full Text] [Related]
25. Prediction of remission or relapse for Graves' hyperthyroidism by the combined determination of stimulating, blocking and binding TSH-receptor antibodies after the withdrawal of antithyroid drug treatment.
Wallaschofski H; Miehle K; Mayer A; Tuschy U; Hentschel B; Paschke R
Horm Metab Res; 2002 Jul; 34(7):383-8. PubMed ID: 12189586
[TBL] [Abstract][Full Text] [Related]
26. Relevance of TSH receptor stimulating and blocking autoantibody measurement for the prediction of relapse in Graves' disease.
Schott M; Minich WB; Willenberg HS; Papewalis C; Seissler J; Feldkamp J; Bergmann A; Scherbaum WA; Morgenthaler NG
Horm Metab Res; 2005 Dec; 37(12):741-4. PubMed ID: 16372227
[TBL] [Abstract][Full Text] [Related]
27. Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases.
Caruso G; Attard M; Caronia A; Lagalla R
Eur J Radiol; 2000 Oct; 36(1):5-10. PubMed ID: 10996751
[TBL] [Abstract][Full Text] [Related]
28. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
[TBL] [Abstract][Full Text] [Related]
29. Levels of autoantibodies against human TSH receptor predict relapse of hyperthyroidism in Graves' disease.
Schott M; Morgenthaler NG; Fritzen R; Feldkamp J; Willenberg HS; Scherbaum WA; Seissler J
Horm Metab Res; 2004 Feb; 36(2):92-6. PubMed ID: 15002058
[TBL] [Abstract][Full Text] [Related]
30. Thyrotropin receptor antibodies in hypothyroid Graves' disease.
Kasagi K; Hidaka A; Nakamura H; Takeuchi R; Misaki T; Iida Y; Konishi J
J Clin Endocrinol Metab; 1993 Feb; 76(2):504-8. PubMed ID: 8094394
[TBL] [Abstract][Full Text] [Related]
31. Prediction of relapse after antithyroid drug therapy of Graves' disease: value of color Doppler sonography.
Saleh A; Cohnen M; Fürst G; Mödder U; Feldkamp J
Exp Clin Endocrinol Diabetes; 2004 Oct; 112(9):510-3. PubMed ID: 15505758
[TBL] [Abstract][Full Text] [Related]
32. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
33. A TSHR-LH/CGR chimera that measures functional thyroid-stimulating autoantibodies (TSAb) can predict remission or recurrence in Graves' patients undergoing antithyroid drug (ATD) treatment.
Giuliani C; Cerrone D; Harii N; Thornton M; Kohn LD; Dagia NM; Bucci I; Carpentieri M; Di Nenno B; Di Blasio A; Vitti P; Monaco F; Napolitano G
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1080-7. PubMed ID: 22492869
[TBL] [Abstract][Full Text] [Related]
34. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
[TBL] [Abstract][Full Text] [Related]
35. Thyroid blood flow in inferior thyroid artery as predictor for increase in levothyroxine dosage during pregnancy in women with Hashimoto's thyroiditis - a retrospective study.
Kurajoh M; Yamasaki A; Nagasaki T; Nagata Y; Yamada S; Imanishi Y; Emoto M; Takahashi K; Yamamoto K; Shintani A; Inaba M
BMC Pregnancy Childbirth; 2019 Jul; 19(1):232. PubMed ID: 31277608
[TBL] [Abstract][Full Text] [Related]
36. GENDER INFLUENCES THE CLINICAL PRESENTATION AND LONG-TERM OUTCOME OF GRAVES DISEASE.
Magri F; Zerbini F; Gaiti M; Capelli V; Ragni A; Rotondi M; Chiovato L
Endocr Pract; 2016 Nov; 22(11):1336-1342. PubMed ID: 27540885
[TBL] [Abstract][Full Text] [Related]
37. Thyroid Doppler ultrasonography and resistive index in the evaluation of the need for ablative or antithyroid drug therapy in Graves' hyperthyroidism.
Wang CY; Chang TC
J Formos Med Assoc; 2001 Nov; 100(11):753-7. PubMed ID: 11802534
[TBL] [Abstract][Full Text] [Related]
38. Superior thyroid artery mean peak systolic velocity for the diagnosis of thyrotoxicosis in Japanese patients.
Uchida T; Takeno K; Goto M; Kanno R; Kubo S; Takahashi S; Azuma K; Sakai K; Fujitani Y; Hirose T; Kawamori R; Watada H
Endocr J; 2010; 57(5):439-43. PubMed ID: 20513982
[TBL] [Abstract][Full Text] [Related]
39. Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: prevalence, natural history, and thyrotropin receptor antibody levels.
Khoo DH; Eng PH; Ho SC; Tai ES; Morgenthaler NG; Seah LL; Fong KS; Chee SP; Choo CT; Aw SE
Thyroid; 2000 Dec; 10(12):1093-100. PubMed ID: 11201855
[TBL] [Abstract][Full Text] [Related]
40. Determination of the levels of anti-thyroid-stimulating hormone receptor antibody with thyroid peroxidase antibody in Omani patients with Graves' disease.
Alnaqdy A; Al-Maskari M
Med Princ Pract; 2005; 14(4):209-12. PubMed ID: 15961927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]